Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Canopy Growth Corporation (T:WEED)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
Company Contact
Address: 1 Hershey Dr
Tel: N/A
IR: See website
Key People
David Eric Klein
Chief Executive Officer, Director
Judy Eun Joo Hong
Chief Financial Officer
Christelle Gedeon
Chief Legal Officer and Company Secretary
Business Overview
Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company delivers innovative products with a focus on cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. It operates through four segments: Canada cannabis, Storz & Bickel, Rest-of-world cannabis, and This Works. Its CPG portfolio features targeted 24-hour skincare and wellness solutions from This Works, gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. The Storz & Bickel segment includes the production, distribution, and sale of vaporizers.
Financial Overview
For the six months ended 30 September 2023, Canopy Growth Corp revenues decreased 35% to C$145.9M. Net loss before extraordinary items decreased 93% to C$158.7M. Revenues reflect Canada segment decrease of 28% to C$112.5M, Germany segment decrease of 8% to C$21.8M. Lower net loss reflects Asset impairment and restructuring costs decrease from C$1.77B (expense) to C$28M (income), FV Adjustments of Financial Investment decrease of 94% to C$17.2M (expense).
Employees: 1,621 as of Mar 31, 2023
Reporting Currency: Canadian Dollars
Enterprise value: $1,189M as of Sep 30, 2023
Annual revenue (TTM): $320.78M as of Sep 30, 2023
EBITDA (TTM): -$330.28M as of Sep 30, 2023
Net annual income (TTM): -$1,132M as of Sep 30, 2023
Free cash flow (TTM): -$519.70M as of Sep 30, 2023
Net Debt Last Fiscal Year: $494.79M as of Sep 30, 2023
Shares outstanding: 732,480,532 as of Oct 2, 2023
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization